Emily Hill
Director of Finance/CFO at REPLIMUNE GROUP, INC.
Net worth: 676 469 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Philip Astley-Sparke | M | 51 | 9 years | |
Robert Coffin | M | 58 | 9 years | |
Sushil Patel | M | 52 | 3 years | |
Dieter Weinand | M | 63 | 6 years | |
Paolo Pucci | M | 63 | 4 years | |
Joseph Slattery | M | 59 | 7 years | |
Hyam Levitsky | M | 66 | 6 years | |
Kapil Dhingra | M | 64 | 7 years | |
Christy Oliger | F | 54 | 3 years | |
Andrew Schwendenman | M | 47 | 4 years | |
Veleka Peeples-Dyer | F | 52 | 1 years | |
Arleen Goldenberg | F | - | - | |
Konstantinos Xynos | M | 57 | 2 years | |
Christopher Sarchi | M | 55 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Carol Mendez | F | - |
Fordham Gabelli School of Business
| 5 years |
Colin Love | M | 65 | 9 years | |
Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
Pamela Esposito | M | 50 | 9 years | |
Mahdi B. Fawzi | M | 76 |
Warner Chilcott Plc
Warner Chilcott Plc Pharmaceuticals: MajorHealth Technology Warner Chilcott Plc is a pharmaceutical company which focuses on women's healthcare, gastroenterology, dermatology and urology segments of the North American. It develops the therapeutic products for the treatment of diseases related to the dermatology, musculoskeletal, women's healthcare and general healthcare and community. The company has manufacturing facilities are located in Puerto Rico, Northern Ireland and Germany. Warner Chilcott was founded in 1968 and is headquartered in Dublin, Ireland. | 2 years |
Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
Jason Victor Ronovech | M | - |
Hamilton College (New York)
| 4 years |
Michael Lyndon Schantz | M | - |
Hamilton College (New York)
| 4 years |
Stephen W. Potter | M | 67 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
Robert Haag | M | 59 |
Hamilton College (New York)
| 3 years |
Daniel Tzortzatos | M | - |
Fordham Gabelli School of Business
| - |
Christina Isacson | F | 45 |
Tufts University School of Medicine
| 5 years |
James Macon | M | 48 |
Hamilton College (New York)
| 4 years |
Ryan McCarthy | M | - |
Hamilton College (New York)
| 4 years |
Grannum R. Sant | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
Michael Richmond | M | - |
Hamilton College (New York)
| 4 years |
Richard T. Dell'Aquila | M | 47 |
Hamilton College (New York)
| 4 years |
St John McGrath | M | - |
Tufts University School of Medicine
| 10 years |
Andrew Barous | M | - |
Hamilton College (New York)
| 4 years |
Daniela Constantino | F | - |
Hamilton College (New York)
| 4 years |
Brian deGuzman | M | 60 |
Tufts University School of Medicine
| 4 years |
Suyash Prasad | M | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 1 years |
Catherine Mari Johnston | F | 41 |
Hamilton College (New York)
| 4 years |
Joseph Hickman | M | - |
Hamilton College (New York)
| 5 years |
Robert Sciaraffo | M | - |
Fordham Gabelli School of Business
| 3 years |
Jonathan R. Tucker | M | - |
Hamilton College (New York)
| 4 years |
John Hotchkiss | M | - |
Fordham Gabelli School of Business
| 2 years |
Michael Pellman-Rowland | M | - |
Hamilton College (New York)
| 4 years |
Nina Sharma | F | - |
Hamilton College (New York)
| 4 years |
Elena Savostianova | F | - |
Hamilton College (New York)
| 4 years |
Ilko Menkov | M | - |
Hamilton College (New York)
| 4 years |
Matthew Silverio | M | - |
Hamilton College (New York)
| 4 years |
Casper Gimand | M | - |
Fordham Gabelli School of Business
| 4 years |
David Greenwald | M | - |
Tufts University School of Medicine
| 4 years |
Evan Teiger | M | - |
Hamilton College (New York)
| 4 years |
Faris Elrabie | M | - |
Fordham Gabelli School of Business
| 2 years |
Heather Hage | F | - |
Hamilton College (New York)
| 4 years |
Sharon Dolan | F | - |
Hamilton College (New York)
| 4 years |
Samuel Earl | M | - |
Hamilton College (New York)
| 4 years |
Machiz Josh | M | - |
Fordham Gabelli School of Business
| 2 years |
Geoff Tomlinson | M | - |
Hamilton College (New York)
| 4 years |
Katie Spencer | F | - |
Hamilton College (New York)
| 4 years |
Molly Fazio Kloos | F | - |
Hamilton College (New York)
| 4 years |
Ross Tubo | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 12 years |
Brad Doppelt | M | - |
Hamilton College (New York)
| 4 years |
Anthony Bruno | M | 68 |
Warner Chilcott Plc
Warner Chilcott Plc Pharmaceuticals: MajorHealth Technology Warner Chilcott Plc is a pharmaceutical company which focuses on women's healthcare, gastroenterology, dermatology and urology segments of the North American. It develops the therapeutic products for the treatment of diseases related to the dermatology, musculoskeletal, women's healthcare and general healthcare and community. The company has manufacturing facilities are located in Puerto Rico, Northern Ireland and Germany. Warner Chilcott was founded in 1968 and is headquartered in Dublin, Ireland. | 11 years |
John Damaske | M | - |
Hamilton College (New York)
| 4 years |
Reed Phillips Coleman | M | - |
Hamilton College (New York)
| 4 years |
Gavin Danaher | M | - |
Hamilton College (New York)
| 4 years |
John P. Clair | M | - |
Hamilton College (New York)
| 4 years |
Jarrel Price | M | - |
Hamilton College (New York)
| 4 years |
Ryan Novak | M | - |
Hamilton College (New York)
| 4 years |
Haider A. Hilaly | M | - |
Hamilton College (New York)
| 4 years |
Molly Fazio | F | - |
Hamilton College (New York)
| 4 years |
Darren S. Sun | M | - |
Hamilton College (New York)
| 4 years |
Michael Joseph Shedosky | M | - |
Hamilton College (New York)
| 4 years |
Peter Tisdall Ostberg | M | - |
Hamilton College (New York)
| 4 years |
Vince Maddi | M | - |
Hamilton College (New York)
| 4 years |
Steven H. Larson | M | - |
Hamilton College (New York)
| 4 years |
W. Carlton Reichel | M | 65 |
Warner Chilcott Plc
Warner Chilcott Plc Pharmaceuticals: MajorHealth Technology Warner Chilcott Plc is a pharmaceutical company which focuses on women's healthcare, gastroenterology, dermatology and urology segments of the North American. It develops the therapeutic products for the treatment of diseases related to the dermatology, musculoskeletal, women's healthcare and general healthcare and community. The company has manufacturing facilities are located in Puerto Rico, Northern Ireland and Germany. Warner Chilcott was founded in 1968 and is headquartered in Dublin, Ireland. | 11 years |
Mark Viviano | M | - |
Hamilton College (New York)
| 4 years |
James O'Mara | M | - |
Hamilton College (New York)
| 4 years |
Chris Abbott | M | - |
Hamilton College (New York)
| 4 years |
Bill DeRosa | M | - |
Hamilton College (New York)
| 4 years |
Douglas Losordo | M | 65 |
Tufts University School of Medicine
| 2 years |
Ilko Menkov | M | - |
Hamilton College (New York)
| 4 years |
Lubi Kutua | M | 43 |
Hamilton College (New York)
| 4 years |
Jeffrey Ball | M | 56 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
Tanya Lewis | F | 53 | 3 years | |
Carol Greve-Philips | F | 71 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 2 years |
Alicia Suarez | F | - |
Hamilton College (New York)
| 4 years |
Drew Conway | M | - |
Hamilton College (New York)
| 4 years |
Jon Jacoby | M | - |
Fordham Gabelli School of Business
| 3 years |
Nora B. Bass | F | - |
Hamilton College (New York)
| 4 years |
Kerry L. Needham | F | - |
Hamilton College (New York)
| 4 years |
Eric Luoma | M | - |
Hamilton College (New York)
| 4 years |
Stephen Kennedy | M | 67 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 18 years |
Dave Martucci | M | - |
Hamilton College (New York)
| 4 years |
Caroline Steers Cameron | F | - |
Hamilton College (New York)
| 4 years |
Matthew Fine | M | - |
Hamilton College (New York)
| 4 years |
Elizabeth G. Trehu | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
Matt McKee | M | - |
Hamilton College (New York)
| 4 years |
Ross O’Brien | M | - |
Fordham Gabelli School of Business
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 96 | 96.97% |
Ireland | 3 | 3.03% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Emily Hill
- Personal Network